University of Minnesota Longitudinal Irritable Bowel Syndrome Omics Study Points to Possible Treatment Target Using transcriptomic, metabolomic, metagenomic, and other data types, a team identified purine metabolism as a potential target for intervention. CRISPR Screening Approach for Mapping Genetic Interactions Uncovers Masked Phenotypes The screen, which multiplexes Cas9 and Cas12a, could be used for functional analysis of large genomic regions in mammalian cells, the researchers said. Genome Canada, Partners Award $42.6M in Genomics, Informatics Research Funding The money is being provided under three Genome Canada funding competitions in partnership with the Canadian federal government and other groups. Immigration to US Quickly Westernizes Gut Microbiome Hmong and Karen immigrants to the US quickly lost diversity in their microbiomes and experienced shifts in the microbes present in their guts. CoreBiome Awarded $220K Translational Product Development Grant The firm will use the grant to accelerate the commercialization of synthetic DNA standards and algorithms licensed from the University of Minnesota. Nov 29, 2016 Some Castration-Resistant Prostate Cancers Marked by Androgen Receptor Rearrangements Sep 9, 2016 Minnesota Researcher Collaborates With Biocept on Bladder, Prostate Cancer Liquid Biopsy Study Aug 8, 2016 Non-CRISPR Genome-Editing Technologies Find Niche in Biotech Applications Premium Jul 26, 2016 Methods for More Accurate Microbiome Studies Could Impact Future Therapeutic Use Premium Jul 5, 2016 LawSeq Effort Aims to Clarify Issues of Consent, Standards, and Liability in Genomic Medicine Premium Jun 10, 2016 NIH Awards $2M Grant for Development of Genomic Medicine Legal Framework Apr 26, 2016 Fecal Transplant Stool Banks Face Potential Regulatory Changes; May Affect Physicians, Patients Premium Feb 25, 2016 Study Detects Gut Microbiome Differences in African Agriculturist, Hunter-Gatherer Populations Oct 29, 2015 Q&A: Susan Wolf on Recommendations for Returning Genomic Results to Families of Study Participants Premium Jul 31, 2015 Genetic Surveillance Study Finds Flu Viruses at Two US Swine Markets Jul 29, 2015 Calyxt Licenses Plant Gene-Targeting IP from U of Minnesota Jun 24, 2015 Microbiome Study of Colorectal Cancer Uncovers Signature of Virulence Genes May 6, 2015 NSF Grants Cornell $5.5M for Genome Editing in Rice Apr 16, 2015 Cellectis Plant Sciences Inks CRISPR/Cas9 Licensing Deal with U of Minnesota Oct 23, 2014 Genomics in the Journals: Oct 23, 2014 Mar 4, 2014 Arno Licenses Technology from U of Minnesota for CDx Development May 23, 2013 Genomics in the Journals: 2013.05.23 May 22, 2013 Debate Heats Up on ACMG's Incidental Findings Recommendations Premium Mar 8, 2013 GenomeWeb Feature: For Plant Studies, Genome Size Poses Unique Challenges Jul 18, 2012 Danforth Center Leads $12M DOE Bioenergy Study Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.